China Medical GatewayLoading your healthcare gateway…

Zhou Na

Zhou Na — Associate Chief Physician — Medical Oncology — Peking Union Medical College Hospital

Specialties

He is a member of the multidisciplinary consultation team for difficult cases of esophageal and gastric tumors at Peking Union Medical College Hospital, focusing on the comprehensive treatment of locally advanced and metastatic esophageal cancer. In addition, he is also experienced in the diagnosis and treatment of other common solid tumors, such as digestive tract tumors, thoracic tumors, and soft tissue sarcomas, and is skilled in applying emerging precision therapies, such as molecular targeted therapy and immunotherapy, to improve patient prognosis and enhance quality of life.

Education

Graduated in 2007 from the seven-year clinical medicine program at China Medical University, obtaining a Bachelor of Medicine and a Master’s degree in Oncology. In 2015, received a PhD degree in Oncology from Peking Union Medical College. From 2017 to 2019, was sent by the government to serve as a consultant physician at Conde S. Januário General Hospital in Macau.

Professional Experience

In 2007, he joined the Department of Internal Medicine at Peking Union Medical College Hospital and began working in the Department of Oncology in 2011, where he has been engaged in clinical work ever since. He is currently a member of the multidisciplinary discussion group for esophageal and gastric malignant tumors at the Difficult and Complicated Cases Consultation Center of Peking Union Medical College Hospital. From 2017 to 2019, he was sent to Conde S. Januário General Hospital in Macau as a consultant physician. In terms of research, his current main focus is on new drug research and biomarker studies for advanced esophageal cancer, and he has led and participated in two Phase II clinical studies of neoadjuvant immunotherapy combined with chemotherapy for esophageal cancer.

Professional Roles

Currently serving as a member of the Youth Committee of the Beijing Oncology Pathology Precision Diagnosis Research Association, a member of the Immunotherapy Adverse Reactions Professional Committee of the Beijing Cancer Prevention and Control Society, a member of the Youth Committee of the Esophageal Cancer Society, and a member of the Neuroendocrine Tumor Branch of the China Medical Promotion Association.

Return to Home